Research Associate II
Gao graduated from Shenyang Normal University of China with a degree in Biology and an MBA. She is a research associate in the Cui Laboratory within the Women's Cancer Program.
Bingchen Han, PhD
Han earned his PhD in cancer biology from the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences in Beijing, China.
Marie Holzapfel, MD
Gynecologic Oncology Medical Fellow
Marie Holzapfel attended medical school at University of Washington Medical Center in Seattle. She thereafter completed a residency in obstetrics and gynecology at Kaiser Permanente Medical Center, Santa Clara. She is currently a third year clinical and research fellow in gynecologic oncology at Cedars-Sinai and UCLA Medical Center. At present, she is working in the Women's Cancer Program laboratory at the Samuel Oschin Cancer Center under the direction of Xiaojiang Cui, PhD, using induced pluripotent stem cells (iPSC) differentiated towards Mullerian epithelium to investigate the molecular mechanisms responsible for serous carcinogenesis and examine the effect of a BRCA1 mutation on this process.
Tilley Jenkins Vogel, MD
Jenkins Vogel attended medical school at The University of North Carolina at Chapel Hill. She thereafter completed a residency in Obstetrics and Gynecology at The University of Washington Medical Center in Seattle. She is currently a clinical and research fellow in Gynecologic Oncology at Cedars-Sinai/UCLA Medical Centers. At present, she is working in the Women's Cancer Program laboratory at the Samuel Oschin Cancer Center under the direction of Xiaojiang Cui, PhD investigating the role of FOXC1 in ovarian cancer metastasis and invasion.
Jeffrey Johnson, MD
Jeffrey Johnson is a resident in general surgery at Cedars-Sinai. He attended medical school at Weill Cornell Medical College. He is working under the mentorship of Xiaojiang Cui, PhD, and Armando Giuliano, MD, FACS, FRCSEd.
Ying Qu, MD, PhD
Qu attended medical school at Shanghai JiaoTong University in China. She finished her PhD program at Shanghai JiaoTong University medical school. She was trained at John Wayne Cancer Institute in Santa Monica on breast cancer translational research. She is currently a postdoctoral fellow in Gynecologic Oncology at Cedars-Sinai/UCLA Medical Centers. At present, she is working in the Women's Cancer Program laboratory at the Samuel Oschin Cancer Center under the direction of Xiaojiang Cui, PhD, investigating the role of TXNL2 in regulating breast cancer malignancy and stem cell property.
Yi Yu, PhD
Yu received her PhD degree from Rush University Medical Center in Chicago. She is currently a postdoctoral scientist in Cui Laboratory. Her research interests focus on generating the stem-like cells using human mammary gland derived epithelial cells. She is also studying the cross talk between FOXC1 and other molecules in breast cancer cells.